Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080416832> ?p ?o ?g. }
- W2080416832 endingPage "672" @default.
- W2080416832 startingPage "661" @default.
- W2080416832 abstract "Summary Estimations of serum lysozyme (muramidase), total B12 binding capacity (TB12BC) and folate were performed in 122 patients: 69 with myeloproliferative disorders (39, polycythaemia rubra vera (PRV); 10, chronic granulocytic leukaemia, Ph1-chromosome positive (CGL); 20, myelosclerosis) and 53 with other disease which affect leucocyte production or turnover (17, monocytic leukaemias; 20, megaloblastic anaemia; 15, neutropenia; and a single case of red cell aplasia progressing to a myeloproliferative disorder). The highest serum lysozyme levels were found in monocytic leukaemia. Serum lysozyme concentrations were also elevated in myelosclerosis and to a lesser extent in CGL and in PRV. High levels in PRV occurred in patients developing myelosclerosis or with active disease, resistant to treatment. Significantly higher concentrations of lysozyme were present in patients with myelosclerosis following PRV than in patients with the primary form of the disease. Patients with myeloproliferative diseases and high lysozyme concentrations tended to have low serum folate levels. Slightly raised levels were found in about 50% of patients with megaloblastic anaemia. Moderately high serum lysozyme concentrations also occurred in patients with neutropenia and hypercellular bone marrows but not in those with hypocellular marrows. TB12BC concentrationswere increased in the myeloproliferative disorders, especially in CGL and to a lesser extent in myelosclerosis and least of all in PRV. The results suggest that serum lysozyme reflects granulocyte turnover (except in monocytic leukaemia) while TB12BC (providing liver function is normal) correlates closely with the total blood (and possibly marrow and splenic) granulocyte pool. The ratio between serum lysozyme and TB12BC proved to be a useful index of the balance between granulocyte turnover and total granulocyte pool in individual patients." @default.
- W2080416832 created "2016-06-24" @default.
- W2080416832 creator A5001740534 @default.
- W2080416832 creator A5008856155 @default.
- W2080416832 creator A5040422772 @default.
- W2080416832 creator A5044725679 @default.
- W2080416832 creator A5051208373 @default.
- W2080416832 date "1971-12-01" @default.
- W2080416832 modified "2023-09-27" @default.
- W2080416832 title "Serum Lysozyme and Vitamin B12Binding Capacity in Myeloproliferative Disorders" @default.
- W2080416832 cites W142039235 @default.
- W2080416832 cites W1967561843 @default.
- W2080416832 cites W1977802642 @default.
- W2080416832 cites W1982922673 @default.
- W2080416832 cites W2005068546 @default.
- W2080416832 cites W2006384887 @default.
- W2080416832 cites W2020701363 @default.
- W2080416832 cites W2041517156 @default.
- W2080416832 cites W2065996061 @default.
- W2080416832 cites W2074759451 @default.
- W2080416832 cites W2077698634 @default.
- W2080416832 cites W2083513936 @default.
- W2080416832 cites W2091726691 @default.
- W2080416832 cites W2096428042 @default.
- W2080416832 cites W2124451817 @default.
- W2080416832 cites W2133804704 @default.
- W2080416832 cites W2147985402 @default.
- W2080416832 cites W2170628857 @default.
- W2080416832 cites W2216167686 @default.
- W2080416832 cites W222736353 @default.
- W2080416832 cites W2315180337 @default.
- W2080416832 cites W2325568505 @default.
- W2080416832 cites W2340329628 @default.
- W2080416832 cites W2341465779 @default.
- W2080416832 cites W2470113857 @default.
- W2080416832 cites W40287076 @default.
- W2080416832 doi "https://doi.org/10.1111/j.1365-2141.1971.tb02728.x" @default.
- W2080416832 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/5289350" @default.
- W2080416832 hasPublicationYear "1971" @default.
- W2080416832 type Work @default.
- W2080416832 sameAs 2080416832 @default.
- W2080416832 citedByCount "30" @default.
- W2080416832 crossrefType "journal-article" @default.
- W2080416832 hasAuthorship W2080416832A5001740534 @default.
- W2080416832 hasAuthorship W2080416832A5008856155 @default.
- W2080416832 hasAuthorship W2080416832A5040422772 @default.
- W2080416832 hasAuthorship W2080416832A5044725679 @default.
- W2080416832 hasAuthorship W2080416832A5051208373 @default.
- W2080416832 hasConcept C109159458 @default.
- W2080416832 hasConcept C126322002 @default.
- W2080416832 hasConcept C203014093 @default.
- W2080416832 hasConcept C2776694085 @default.
- W2080416832 hasConcept C2776966407 @default.
- W2080416832 hasConcept C2777063308 @default.
- W2080416832 hasConcept C2777983669 @default.
- W2080416832 hasConcept C2778740236 @default.
- W2080416832 hasConcept C2779405478 @default.
- W2080416832 hasConcept C2779750884 @default.
- W2080416832 hasConcept C2780007613 @default.
- W2080416832 hasConcept C2780525284 @default.
- W2080416832 hasConcept C2781087989 @default.
- W2080416832 hasConcept C28328180 @default.
- W2080416832 hasConcept C2910274570 @default.
- W2080416832 hasConcept C54355233 @default.
- W2080416832 hasConcept C55493867 @default.
- W2080416832 hasConcept C71924100 @default.
- W2080416832 hasConcept C86803240 @default.
- W2080416832 hasConcept C90924648 @default.
- W2080416832 hasConceptScore W2080416832C109159458 @default.
- W2080416832 hasConceptScore W2080416832C126322002 @default.
- W2080416832 hasConceptScore W2080416832C203014093 @default.
- W2080416832 hasConceptScore W2080416832C2776694085 @default.
- W2080416832 hasConceptScore W2080416832C2776966407 @default.
- W2080416832 hasConceptScore W2080416832C2777063308 @default.
- W2080416832 hasConceptScore W2080416832C2777983669 @default.
- W2080416832 hasConceptScore W2080416832C2778740236 @default.
- W2080416832 hasConceptScore W2080416832C2779405478 @default.
- W2080416832 hasConceptScore W2080416832C2779750884 @default.
- W2080416832 hasConceptScore W2080416832C2780007613 @default.
- W2080416832 hasConceptScore W2080416832C2780525284 @default.
- W2080416832 hasConceptScore W2080416832C2781087989 @default.
- W2080416832 hasConceptScore W2080416832C28328180 @default.
- W2080416832 hasConceptScore W2080416832C2910274570 @default.
- W2080416832 hasConceptScore W2080416832C54355233 @default.
- W2080416832 hasConceptScore W2080416832C55493867 @default.
- W2080416832 hasConceptScore W2080416832C71924100 @default.
- W2080416832 hasConceptScore W2080416832C86803240 @default.
- W2080416832 hasConceptScore W2080416832C90924648 @default.
- W2080416832 hasIssue "6" @default.
- W2080416832 hasLocation W20804168321 @default.
- W2080416832 hasLocation W20804168322 @default.
- W2080416832 hasOpenAccess W2080416832 @default.
- W2080416832 hasPrimaryLocation W20804168321 @default.
- W2080416832 hasRelatedWork W1964010524 @default.
- W2080416832 hasRelatedWork W1967386430 @default.
- W2080416832 hasRelatedWork W2010236775 @default.
- W2080416832 hasRelatedWork W2027142959 @default.
- W2080416832 hasRelatedWork W2035973992 @default.